Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Technical debt: A growing concern in healthcare

Better technology, new software, and mergers and migrations are having a significant impact on the IT operations of hospitals and healthcare systems across the country. As healthcare providers continue to adopt and integrate new applications designed to solve a bevy of problems and improve efficiency, a new challenge has emerged: technical debt. What is technical…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Better technology, new software, and mergers and migrations are having a significant impact on the IT operations of hospitals and healthcare systems across the country. As healthcare providers continue to adopt and integrate new applications designed to solve a bevy of problems and improve efficiency, a new challenge has emerged: technical debt.

What is technical debt?

This term is also known as software or code debt. Technical debt accrues when an IT professional uses a quick fix in software or when creating interfaces. This band-aid solution will require updates and repairs in the future. Some professionals knowingly take debt on to fix an immediate problem or when a quick solution may result in significant gains in a short time. However, the debt is often completely unnecessary.

Like with a credit card or personal loan, technical debt comes with interest. Over time, it can cost significantly more hours spent coding to fix the initial patch than it would cost to solve the problem correctly in the first place. Also, as with a personal credit card, software debt can add up quickly and cause a tidal wave of issues.

As it relates to interfaces, technical debt can be reduced or eliminated by adhering to healthcare standards.

How technical debt affects healthcare

Hoarding code debt hasn’t hit the healthcare industry yet as hard as it has other industries. However, healthcare organizations are every bit as susceptible to the problems of technical debt as other businesses.

As a health IT professional, imagine all the code you and your team has written in your career. Now, consider the many places that your code still runs and how many times someone else has had to change that code to meet expanding needs. It’s easy to see that technical debt is building up in our industry. It’s also easy to see why some interface teams are reluctant to integrate new applications.

As more healthcare companies merge, consolidate, and expand, more IT professionals will need to write additional code to combine and scale whole systems. Eventually, technical debt from custom code will become completely unmanageable. When you consider that the health and safety of patients remain on the line, this compounding disorder is an unnecessary risk.

Technical debt = real money

Not only can you use monetary debt as an analogy for software debt, but significant technical debt can also have dire effects on the bottom line. In fact, just one line of code in debt can cost $3.61 in the long run. When you’re running Java, that cost jumps to $5.42 per line. Once again, think back to the many lines of code you have written in your career and consider how many will need reworking. The costs add up as superfluous hours of IT time must be spent unraveling messy code.

The solution is better software

If you prefer not to accrue debt when purchasing a fancy new television or car, you save up your money and pay cash instead. While it may take longer to achieve your purpose, it will cost less in the long run. The same idea goes for technical debt. To avoid taking on too much code debt, explore the correct solution whenever possible. The investment is well worth the effort down the line.

Corepoint Integration Engine helps healthcare IT professionals do precisely that. Rather than relying on an open coding environment, the engine allows interface creation in a standards-based GUI environment. This method eliminates the need for hastily written code that future staff won’t understand. Of course, for the 5% of interfaces that require custom code, our engine allows for this as well. It’s all the flexibility you need without the technical debt.

All interfaces in Corepoint engine adheres to HL7 standards, which allows any analyst or developer to look at an interface in the engine and find a reliable solution to the issue at hand. When the quick fix is also the right fix, everything runs better.

Learn more about the Corepoint engine and how it can help your business.

Read more at corepointhealth.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512